Soleno Therapeutics, Inc. (SLNO) Misses Q1 EPS by 6c

Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q1 EPS of ($0.95), $0.06 worse than the analyst estimate of ($0.89).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.

You May Also Be Interested In

• PG&E Corp, Edison spike on chatter
• Action Behavior Centers' Family Advocacy Team Meets with Congressional Leaders in Washington, D.C., to Discuss Access to ABA Therapy for Autism
• Uniserve CEO Gautam Lohia to Speak at CanITCon 2026; Supports UBC Sauder Powerhouse Project